These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 27358242)

  • 21. Prevalence and importance of comorbidities in patients with heart failure.
    Triposkiadis FK; Skoularigis J
    Curr Heart Fail Rep; 2012 Dec; 9(4):354-62. PubMed ID: 22918666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial).
    Böhm M; Robertson M; Ford I; Borer JS; Komajda M; Kindermann I; Maack C; Lainscak M; Swedberg K; Tavazzi L
    Am J Cardiol; 2015 Dec; 116(12):1890-7. PubMed ID: 26508709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-cardiac comorbidities in heart failure: an update on diagnostic and management strategies.
    Kodur N; Tang WHW
    Minerva Med; 2024 Jun; 115(3):337-353. PubMed ID: 38899946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation of left ventricular ejection fraction and clinical features or co-morbidities to outcomes among patients hospitalized for acute heart failure syndromes.
    Kajimoto K; Sato N; Takano T;
    Am J Cardiol; 2015 Feb; 115(3):334-40. PubMed ID: 25476557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low myocardial protein kinase G activity in heart failure with preserved ejection fraction.
    van Heerebeek L; Hamdani N; Falcão-Pires I; Leite-Moreira AF; Begieneman MP; Bronzwaer JG; van der Velden J; Stienen GJ; Laarman GJ; Somsen A; Verheugt FW; Niessen HW; Paulus WJ
    Circulation; 2012 Aug; 126(7):830-9. PubMed ID: 22806632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis, Clinical Course, and 1-Year Outcome in Patients Hospitalized for Heart Failure With Preserved Ejection Fraction (from the Polish Cohort of the European Society of Cardiology Heart Failure Long-Term Registry).
    Kapłon-Cieślicka A; Tymińska A; Peller M; Balsam P; Ozierański K; Galas M; Marchel M; Crespo-Leiro MG; Maggioni AP; Drożdż J; Filipiak KJ; Opolski G
    Am J Cardiol; 2016 Aug; 118(4):535-42. PubMed ID: 27374606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of SERVE-HF on management of sleep disordered breathing in heart failure: a call for further studies.
    Linz D; Fox H; Bitter T; Spießhöfer J; Schöbel C; Skobel E; Türoff A; Böhm M; Cowie MR; Arzt M; Oldenburg O
    Clin Res Cardiol; 2016 Jul; 105(7):563-70. PubMed ID: 26872963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic obstructive airway disease among patients hospitalized with acute heart failure; clinical characteristics, precipitating factors, management and outcome: Observational report from the Middle East.
    Khafaji HA; Sulaiman K; Singh R; Alhabib KF; Asaad N; Alsheikh-Ali A; Al-Jarallah M; Bulbanat B; Almahmeed W; Ridha M; Bazargani N; Amin H; Al-Motarreb A; Faleh HA; Elasfar A; Panduranga P; Suwaidi JA
    Acute Card Care; 2015 Dec; 17(4):55-66. PubMed ID: 27712142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.
    Brouwers FP; de Boer RA; van der Harst P; Voors AA; Gansevoort RT; Bakker SJ; Hillege HL; van Veldhuisen DJ; van Gilst WH
    Eur Heart J; 2013 May; 34(19):1424-31. PubMed ID: 23470495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
    Kontogeorgos S; Thunström E; Johansson MC; Fu M
    Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction.
    Melenovsky V; Hwang SJ; Redfield MM; Zakeri R; Lin G; Borlaug BA
    Circ Heart Fail; 2015 Mar; 8(2):295-303. PubMed ID: 25593126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes and worsening renal function in patients hospitalized with heart failure with preserved ejection fraction.
    Sharma K; Hill T; Grams M; Daya NR; Hays AG; Fine D; Thiemann DR; Weiss RG; Tedford RJ; Kass DA; Schulman SP; Russell SD
    Am J Cardiol; 2015 Nov; 116(10):1534-40. PubMed ID: 26410603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Predictive variables for mortality in elderly patients hospitalized due to heart failure with preserved ejection fraction].
    Carrasco-Sánchez FJ; Páez-Rubio MI; García-Moreno JM; Vázquez-García I; Araujo-Sanabria J; Pujo-de la Llave E
    Med Clin (Barc); 2013 Nov; 141(10):423-9. PubMed ID: 23790575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comorbidities in Heart Failure: Are There Gender Differences?
    Hopper I; Kotecha D; Chin KL; Mentz RJ; von Lueder TG
    Curr Heart Fail Rep; 2016 Feb; 13(1):1-12. PubMed ID: 26829930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extra-cardiac targets in the management of cardiometabolic disease: Device-based therapies.
    Jorbenadze A; Fudim M; Mahfoud F; Adamson PB; Bekfani T; Wachter R; Sievert H; Ponikowski PP; Cleland JGF; Anker SD
    ESC Heart Fail; 2021 Aug; 8(4):3327-3338. PubMed ID: 34002946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronary artery disease and 10-year outcome after hospital admission for heart failure with preserved and with reduced ejection fraction.
    Rusinaru D; Houpe D; Szymanski C; Lévy F; Maréchaux S; Tribouilloy C
    Eur J Heart Fail; 2014 Sep; 16(9):967-76. PubMed ID: 25111982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and predisposing conditions for atrial fibrillation in hospitalised patients with hypertension.
    Gorczyca-Michta I; Wożakowska-Kapłon B; Tomasik E
    Kardiol Pol; 2013; 71(4):352-8. PubMed ID: 23788340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is Heart Failure with Preserved Ejection Fraction a Kidney Disorder?
    Shah KS; Fang JC
    Curr Hypertens Rep; 2019 Oct; 21(11):86. PubMed ID: 31599363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of three major co-morbidities on quality of life and outcome of patients with heart failure with reduced ejection fraction.
    Benes J; Kotrc M; Jarolim P; Hoskova L; Hegarova M; Dorazilova Z; Podzimkova M; Binova J; Lukasova M; Malek I; Franekova J; Jabor A; Kautzner J; Melenovsky V
    ESC Heart Fail; 2021 Apr; 8(2):1417-1426. PubMed ID: 33512782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.